首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1572383

生物成像試劑市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Biological Imaging Reagents Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月13日 | 出版商:

Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在慢性病盛行率上升以及研發大量投資的推動下，全球生物成像試劑市場在 2024 年至 2032 年間將呈現 7.3% 的複合年成長率。推動生物成像試劑產業成長的因素包括全球健康意識的提高、成像技術的技術進步以及診斷成像程序數量的增加。隨著全球醫療保健系統強調早期疾病檢測和個人化醫療，對先進成像試劑的需求激增。此外，人工智慧和機器學習在成像技術中的整合正在提高診斷準確性，進一步推動生物成像試劑市場的成長。

此外，多模式成像技術的日益使用正在增加對生物成像試劑的需求，改變生物醫學研究、臨床診斷和治療開發等領域。透過結合 MRI、PET、CT 和螢光顯微鏡等模式，多模式成像可為生物過程和疾病提供更清晰、更精確的視野。這種整體方法增強了對醫療狀況的識別和理解，推動了對與多種模式相容的各種成像試劑的需求。

整個生物成像試劑產業根據產品類型、影像模式、應用、最終用途和地區進行分類。

生物成像試劑市場按產品類型分為造影劑、光學試劑和核試劑，其中造影劑到2023年將佔據44.8%的領先佔有率。。隨著醫療保健系統在全球範圍內優先考慮診斷的準確性，對提高成像清晰度和準確性的試劑的需求變得至關重要。這一趨勢凸顯了現代醫學對先進影像技術的日益依賴。

生物成像試劑市場的應用領域包括臨床診斷、藥物發現、研究等，預計到2032年臨床診斷將達到97億美元。關重要。隨著醫療保健系統在全球範圍內優先考慮診斷的準確性，對提高成像清晰度和準確性的試劑的需求變得至關重要。這一趨勢凸顯了現代醫學對先進影像技術的日益依賴。

北美生物成像試劑產業預計到 2023 年價值 47 億美元，複合年成長率為 6.9%。北美的生物成像試劑產業得到了其強大的醫療基礎設施的支持，其特點是最先進的成像技術和設施。這種先進的基礎設施不僅推動了對複雜成像試劑的需求，而且使該地區成為生物醫學研究和創新的領導者。此外，該地區在大量公共和私人投資的支持下對研發的承諾，加速了尖端成像技術和試劑的開發和採用。

產業生態系統分析
產業影響力
- 成長動力
  - 慢性病盛行率上升
  - 多模態成像的日益採用
  - 增加研發投入
- 產業陷阱與挑戰
  - 嚴格的政府法規
成長潛力分析
報銷場景
監管環境
技術景觀
波特的分析
PESTEL分析
差距分析
未來市場趨勢

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品類型，2021 - 2032 年

主要趨勢
對照試劑
光學試劑
核試劑

第 6 章：市場估計與預測：按影像方式，2021 - 2032 年

主要趨勢
核磁共振成像
超音波
X光和CT
光學成像
核子造影
- 寵物
- SPECT
- 其他核子造影方式

第 7 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
臨床診斷
- 腫瘤學
- 心臟病學
- 神經病學
- 其他臨床診斷應用
藥物發現與開發
研究與創新
其他應用

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院
診斷影像中心
研究和學術機構
製藥和生物技術公司
其他最終用戶

第 9 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Bayer AG
Bracco
Carl Zeiss
Cell Signaling Technology
Danaher
General Electric Company
Guerbet
Jubilant Pharmova Limited
Luminex Corporation
Nikon Corporation
Novartis AG
Olympus Corporation
Promega Corporation
Sartorius AG
Thermo Fisher Scientific Inc.

簡介目錄

Product Code: 10770

The Global Biological Imaging Reagents Market will show a 7.3% CAGR between 2024 and 2032, fueled by the rising prevalence of chronic diseases and significant investments in research and development. Factors driving the growth of the Biological Imaging Reagents industry include the rising global health awareness, technological advancements in imaging techniques, and the increasing number of diagnostic imaging procedures. As healthcare systems worldwide emphasize early disease detection and personalized medicine, the demand for advanced imaging reagents has surged. Furthermore, the integration of AI and machine learning in imaging technologies is enhancing diagnostic accuracy, further propelling the growth of the biological imaging reagents market.

Further, the growing use of multimodal imaging techniques is boosting the demand for biological imaging reagents, transforming fields like biomedical research, clinical diagnostics, and therapeutic development. By combining modalities like MRI, PET, CT, and fluorescence microscopy, multimodal imaging offers a clearer and more precise view of biological processes and diseases. This holistic method enhances the identification and understanding of medical conditions, fueling the need for a variety of imaging reagents compatible with multiple modalities.

The overall Biological Imaging Reagents Industry is sorted based on product type, image modality, application, end use, and region.

The biological imaging reagents market is segmented by product type into contrast reagents, optical reagents, and nuclear reagents, with contrast reagents commanding a leading share of 44.8% in 2023. The growing emphasis on early disease detection and personalized medicine is driving the demand for specific imaging agents. As healthcare systems globally prioritize precision in diagnostics, the need for agents that enhance imaging clarity and accuracy becomes paramount. This trend underscores the increasing reliance on advanced imaging techniques in modern medicine.

The biological imaging reagents market's application segments include clinical diagnostics, drug discovery, research, and others, with clinical diagnostics expected to reach USD 9.7 billion by 2032. The rising global health awareness and the push for early disease detection are pivotal in driving the demand for imaging agents. As healthcare systems globally prioritize precision in diagnostics, the need for agents that enhance imaging clarity and accuracy becomes paramount. This trend underscores the increasing reliance on advanced imaging techniques in modern medicine.

North America biological imaging reagents industry, valued at USD 4.7 billion in 2023, is set to grow at a CAGR of 6.9%. North America's biological imaging reagents industry is bolstered by its robust healthcare infrastructure, characterized by state-of-the-art imaging technologies and facilities. This advanced infrastructure not only drives the demand for sophisticated imaging reagents but also positions the region as a leader in biomedical research and innovation. Furthermore, the region's commitment to R&D, backed by substantial public and private investments, accelerates the development and adoption of cutting-edge imaging technologies and reagents.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of chronic conditions
  - 3.2.1.2 Growing adoption of multi-modal imaging
  - 3.2.1.3 Increasing investments in research and development
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Stringent government regulations
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Regulatory landscape
3.6 Technological landscape
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Gap analysis
3.10 Future market trends

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Contrast reagents
5.3 Optical reagents
5.4 Nuclear reagents

Chapter 6 Market Estimates and Forecast, By Imaging Modality, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 MRI
6.3 Ultrasound
6.4 X-ray and CT
6.5 Optical imaging
6.6 Nuclear imaging
- 6.6.1 PET
- 6.6.2 SPECT
- 6.6.3 Other nuclear imaging modalities

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Clinical diagnostics
- 7.2.1 Oncology
- 7.2.2 Cardiology
- 7.2.3 Neurology
- 7.2.4 Other clinical diagnostic application
7.3 Drug discovery and development
7.4 Research and innovation
7.5 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Diagnostic imaging centers
8.4 Research and academic institutes
8.5 Pharmaceutical and biotechnology companies
8.6 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa